申请人:Van Emelen Kristof
公开号:US20050096378A1
公开(公告)日:2005-05-05
The present invention concerns compounds of formula (I)
a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein -Z
1
-Z
2
- is a bivalent radical; R
1
, R
2
and R
3
are each independently selected from hydrogen, C
1-6
alkyl, hydroxy, halo and the like; or when R
1
and R
2
are on adjacent carbon atoms, R
1
and R
2
taken together may form a bivalent radical of formula; Alk
1
and Alk
2
are optionally substituted C
1-6
alkanediyl; R
6
is hydrogen or phenylmethyl; R
5
is a radical of formula
wherein n is 1 or 2; p
1
is 0, and p
2
is 1 or 2; or p
1
is 1 or 2, and p
2
is 0; X is oxygen, sulfur or ═NR
9
; Y is oxygen or sulfur; R
7
is hydrogen, C
1-6
alkyl, C
3-6
cycloalkyl, phenyl or phenylmethyl; R
8
is C
1-6
alkyl, C
3-6
cycloalkyl phenyl or phenylmethyl; R
9
is cyano, C
1-6
alkyl, C
3-6
cyclo-alkyl, C
1-6
alkyloxycarbonyl or aminocarbonyl; R
10
is hydrogen or C
1-6
alkyl; and Q is a bivalent radical. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for treating conditions which are related to impaired fundic relaxation.
本发明涉及式(I)的化合物,其立体化学异构体形式,其N-氧化物形式或其药学上可接受的酸加合盐,其中-Z1-Z2-是二价基团;R1,R2和R3分别独立地选择自氢,C1-6烷基,羟基,卤素等;或当R1和R2在相邻碳原子上时,R1和R2结合在一起可以形成式的二价基团;Alk1和Alk2是可选择的取代的C1-6烷二基基团;R6是氢或苯甲基;R5是式其中n为1或2;p1为0,p2为1或2;或p1为1或2,p2为0;X是氧,硫或═NR9;Y是氧或硫;R7是氢,C1-6烷基,C3-6环烷基,苯基或苯甲基;R8是C1-6烷基,C3-6环烷基,苯基或苯甲基;R9是氰基,C1-6烷基,C3-6环烷基,C1-6烷氧基羰基或氨基羰基;R10是氢或C1-6烷基;Q是二价基团。公开了制备所述产品的方法,包括所述产品的配方以及其作为药物的用途,特别是用于治疗与胃底松弛受损相关的疾病。